Back to search

Aristotle University Of Thessaloniki (AUTH)

Η επίδραση των γενετικών παραγόντων στην αποτελεσματικότητα της αντιυπερτασικής θεραπείας

Abstract

dc:description

Background: Central artery stiffness, a result of progressive arterial aging, emerges recently as an independent indicator of cardiovascular risk. The aim of the present longitudinal study was to investigate the impact of genetic factors and different antihypertensive agents on the progression of the aortic stiffness, over a 6-year period, in treated and untreated hypertensives and normotensive subjects. Methods: Data for the present analysis were gathered from 458 subjects who had 2 health checkups over a 6-years time interval and were not under treatment for hypertension at the time of the first visit. Carotid - femoral pulse wave velocity (PWV) was used to evaluate aortic stiffness in 357 subjects who remained untreated throughout the follow-up period, and in 101 subjects who finally received some kind of antihypertensive therapy during the follow-up, and were under treatment at the second visit. Eight different genetic polymorphisms of the renin-angiotensin-aldosterone system (RAAS) and endothelial nitric oxide synthase system (ENOS) were examined in both groups. Results: Annual rates of progression in PWV were significantly higher in the untreated subjects than in treated group, but the difference did not remain significant after adjustment for the difference of the mean arterial pressure (MAP). No polymorphism was shown to alter significantly the progression of the aortic stiffness in untreated subjects, but in the treated group, the ENOS Glu298Asp polymorphism (T allele carriers) was associated with significantly slower progression of PWV. Among various treatments, only the presence of diuretics was associated with significant regression of the aortic stiffness. A similar trend was also observed for the angiotensin converting enzyme inhibitors (ACEI), but did not reach statistical significance after adjustment for MAP. The coexistence of diuretic treatment and the ENOS Glu298Asp polymorphism (T allele carriers) was associated with very significant regression of the aortic stiffness, when treated subjects were classified according to combined presence or absence of a diuretic agent and T allele carriage. Finally, among subjects who were classified as hypertensive at the time of the first visit, those who remained treatment - free throughout the follow-up period exhibited significantly higher progression of the PWV compared to subjects who were under treatment at the second visit. Conclusions: In subjects treated for essential hypertension, diuretic agents and T allele carriage of the ENOS Glu298Asp polymorphism are both important determinants of slower progression of aortic stiffness. Longstanding, untreated hypertension is associated by accelerated progression of aortic stiffness whereas antihypertensive treatment seems to attenuate this process.

Degree

thesis:*
Grantor dc:publisher
Aristotle University Of Thessaloniki (AUTH)
Year dc:date
2008

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Adamopoulos, Chrysostomos
  • Αδαμόπουλος, Χρυσόστομος

Subjects

dc:subject × 12

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/24737

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Adamopoulos, Chrysostomos; Αδαμόπουλος, Χρυσόστομος. Η επίδραση των γενετικών παραγόντων στην αποτελεσματικότητα της αντιυπερτασικής θεραπείας. Aristotle University Of Thessaloniki (AUTH), 2008. http://hdl.handle.net/10442/hedi/24737